Depression and comorbid medical illness: The National Institute of Mental Health perspective

Biological Psychiatry

Volumn 54, Issue 3, 2003, Pages 184-186

  Stover, Ellen ^a   Fenton, Wayne ^a   Rosenfeld, Anne ^a   Insel, Thomas R ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

BEHAVIOR THERAPY; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; HUMAN; MEDICAL RESEARCH; MENTAL DISEASE; MENTAL HEALTH; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; MENTAL HEALTH SERVICE; PATHOPHYSIOLOGY; UNITED STATES;

BIOMEDICAL RESEARCH; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.); UNITED STATES;

EID: 0141721306     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00272-5     Document Type: Editorial

References (15)

1. Bejjani B.P., Damier P., Arnulf I., Thivard L., Bonnet A.M., Dormont D., et al. Transient acute depression induced by high-frequency deep brain stimulation. N Engl J Med. 340:1999;1476-1480.
2. Callahan E.J., Bertakis K.D., Azari R., Helms L.J., Robbins J., Miller J. Depression in primary care Patient factors that influence recognition . Fam Med. 29:1997;172-176.
3. Feinstein A.R. Clinical Judgment. 1967;Robert E. Krieger Publishing, Huntington, NY.
4. Glassman A.H., O'Connor C.M., Califf R.M., Swedberg K., Schwartz P., Bigger J.T., et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 288:2002;701-709.
5. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.-U., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States Results from the National Comorbidity Survey . Arch Gen Psychiatry. 51:1994;8-18.
6. Kouzis A., Eaton W.W., Leaf P.J. Psychopathology and mortality in the general population. Soc Psychiatry Psychiatr Epidemiol. 30:1995;165-170.
7. Kraemer H.C. Statistical issues in assessing comorbidity. Stat Med. 14:1995;721-733.
8. Kraemer H.C., Stice A., Kazdin A., Kupfer D. How do risk factors work together to produce an outcome? Mediators, moderators, independent, overlapping and pseudo risk factors. Am J Psychiatry. 158:2001;848-856.
9. Krishnan R.R., Delong M., Kraemer H., Carney R., Spiegel D., Gordon C., et al. Comorbidity of depression with other medical diseases in the elderly. Biol Psychiatry. 52:2002;559-588.
10. Lilienfeld S.O., Waldman I.D., Israel A.C. A critical examination of the use of the term and concept of comorbidity in psychopathology research. Clin Psychol Sci Pract. 1:1994;71-83.
11. Merikangas K, Angst J, Eaton W, Canino G, Rubio-Stipec H, Wacker H, et al (1996): Comorbidity and boundaries of affective disorders with anxiety disorders and substance abuse: Results of an international task force. Br J Psychiatry 30(suppl):68-67.
12. Murray J.L., Lopez A.D.L. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. 1996;Harvard University Press, Cambridge, MA.
13. Narushima K., Kosier J.T., Robinson R.G. Preventing poststroke depression A 12-week double-blind randomized treatment trial and 21-month follow-up . J Nerv Ment Dis. 190:2002;296-303.
14. Breaking ground, breaking through The strategic plan for mood disorders research of the National Institute of Mental Health . Biol Psychiatry. 52:(6):2002;. (entire issue).
15. NHLBI Communications Office (2001): Study finds no reduction in deaths or heart attacks in heart disease patients treated for depression and low social support. Press release dated November 12, 2001. Available at: http://www.nhlbi.nih.gov/new/press/01-11-13.htm. Accessed April 1, 2003.